Journey Medical CorporationDERMNASDAQ
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q3 2025 | -100.00% |
| Q2 2025 | 12.42% |
| Q1 2025 | 5.06% |
| Q4 2024 | -11.72% |
| Q3 2024 | 10.34% |
| Q2 2024 | 22.66% |
| Q1 2024 | -14.44% |
| Q4 2023 | 13.95% |
| Q3 2023 | -28.87% |
| Q2 2023 | -8.66% |
| Q1 2023 | -4.97% |
| Q4 2022 | -10.20% |
| Q3 2022 | 2.53% |
| Q2 2022 | 3.23% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | -100.00% |
| Q1 2020 | 0.00% |
| Q3 2019 | -26.80% |
| Q2 2019 | 30.09% |
| Q1 2019 | -7.60% |
| Q4 2018 | 6.41% |
| Q3 2018 | 21.44% |
| Q2 2018 | 28.87% |
| Q1 2018 | 16.16% |
| Q4 2017 | -81.64% |
| Q3 2017 | 991.55% |
| Q2 2017 | 19.96% |
| Q1 2017 | 19.31% |
| Q4 2016 | 14.71% |
| Q3 2016 | 29.86% |
| Q2 2016 | 8.00% |
| Q1 2016 | -20.65% |
| Q4 2015 | 58.77% |
| Q3 2015 | 21.73% |